China Immunotech (Beijing) Biotechnology Co LTD
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From China Immunotech (Beijing) Biotechnology Co LTD
Two IPOs and 12 venture capital and private equity deals in China raised a combined $1bn in a hectic few weeks of October.
With nearly 3,500 therapies in development globally, and almost $480m in start-up financing in Q1 of 2021 alone, the cell, gene and RNA therapy area is seeing a sharp rise in development and attention.